3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection
US7718767B2 · kind B2 · utility
11Cited by
23References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 21, 2006 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Mar 21, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K7/645
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to cyclosporin derivatives of general formula (I):wherein A, B, R1, R2 and X are as defined in the specification, and pharmaceutical compositions prepared from the same, for use in treatment of hepatitis C virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.